Inogen Secures FDA 510(k) Clearance For SIMEOX 200 Airway Clearance Device

(RTTNews) - Inogen, Inc. (INGN), Monday announced that the company has received U.S. Food and Drug Administration 510(k) clearance for the SIMEOX 200 Airway Clearance Device, designed to help patients with chronic lung diseases associated with mucus hypersecretion and mucus retention.

The device promotes and improves bronchial drainage by enhancing mobilization of bronchial secretions via high frequency oscillatory vibrations and intermittent negative pressure to the airway during exhalation, the company explained.

Inogen intends to pursue a limited launch of SIMEOX 200 in targeted sites in 2025.

During the pre-market hours, Inogen's stock is trading at $8.90, up 3.73 percent on the Nasdaq.